IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0007287.html
   My bibliography  Save this article

Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer

Author

Listed:
  • Andrea Sartore-Bianchi
  • Federica Di Nicolantonio
  • Michele Nichelatti
  • Francesca Molinari
  • Sara De Dosso
  • Piercarlo Saletti
  • Miriam Martini
  • Tiziana Cipani
  • Giovanna Marrapese
  • Luca Mazzucchelli
  • Simona Lamba
  • Silvio Veronese
  • Milo Frattini
  • Alberto Bardelli
  • Salvatore Siena

Abstract

Background: KRAS mutations occur in 35–45% of metastatic colorectal cancers (mCRC) and preclude responsiveness to EGFR-targeted therapy with cetuximab or panitumumab. However, less than 20% patients displaying wild-type KRAS tumors achieve objective response. Alterations in other effectors downstream of the EGFR, such as BRAF, and deregulation of the PIK3CA/PTEN pathway have independently been found to give rise to resistance. We present a comprehensive analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression in mCRC patients treated with cetuximab or panitumumab, with the aim of clarifying the relative contribution of these molecular alterations to resistance. Methodology/Principal Findings: We retrospectively analyzed objective tumor response, progression-free (PFS) and overall survival (OS) together with the mutational status of KRAS, BRAF, PIK3CA and expression of PTEN in 132 tumors from cetuximab or panitumumab treated mCRC patients. Among the 106 non-responsive patients, 74 (70%) had tumors with at least one molecular alteration in the four markers. The probability of response was 51% (22/43) among patients with no alterations, 4% (2/47) among patients with 1 alteration, and 0% (0/24) for patients with ≥2 alterations (p

Suggested Citation

  • Andrea Sartore-Bianchi & Federica Di Nicolantonio & Michele Nichelatti & Francesca Molinari & Sara De Dosso & Piercarlo Saletti & Miriam Martini & Tiziana Cipani & Giovanna Marrapese & Luca Mazzucchel, 2009. "Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer," PLOS ONE, Public Library of Science, vol. 4(10), pages 1-9, October.
    • Handle: RePEc:plo:pone00:0007287
    DOI: 10.1371/journal.pone.0007287
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007287
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007287&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0007287?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zi-Xu Yuan & Xiao-Yan Wang & Qi-Yuan Qin & De-Feng Chen & Qing-Hua Zhong & Lei Wang & Jian-Ping Wang, 2013. "The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti- EGFR Monoclonal Antibodies: A Meta-Analysis," PLOS ONE, Public Library of Science, vol. 8(6), pages 1-10, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0007287. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.